Department of Materials Sciences and Engineering, National Chiao Tung University, Hsinchu, Taiwan.
ACS Nano. 2012 Mar 27;6(3):2558-65. doi: 10.1021/nn205023w. Epub 2012 Feb 16.
Cocktail therapy by delivering multiple drugs to diseased cells can elicit synergistic therapeutic effects and better modulate the complex cell-signaling network. Besides selection of drug combinations, a difficulty in delivery is how to encapsulate drugs with various solubility into a common vehicle, particularly when both hydrophobic and hydrophilic compounds are involved. Furthermore, it is highly desirable that the drug release profile can be controlled in an on-demand fashion for balanced therapeutic and side effects. On the basis of a simple and scalable double emulsion approach, we report a new class of nanocapsules that can solve these problems simultaneously. Further linking the nanocapsules with peptides targeting cell surface integrins leads to significantly enhanced cell uptake of the nanocapsules. Intracellular drug release triggered by external stimuli has also been achieved without affecting cell viability. Further development of this technology should open exciting opportunities in treating tough diseases such as cancer, cardiovascular diseases, neurological disorders, and infectious diseases.
鸡尾酒疗法通过向病变细胞输送多种药物,可以产生协同的治疗效果,并更好地调节复杂的细胞信号网络。除了药物组合的选择外,输送的一个难点是如何将各种溶解度的药物封装到一个通用载体中,特别是当涉及疏水性和亲水性化合物时。此外,非常希望药物释放曲线可以按需控制,以实现平衡的治疗效果和副作用。基于一种简单且可扩展的双重乳液方法,我们报告了一类新的纳米胶囊,它可以同时解决这些问题。进一步将纳米胶囊与靶向细胞表面整合素的肽连接起来,可以显著提高纳米胶囊的细胞摄取率。通过外部刺激触发细胞内药物释放,同时不影响细胞活力。这项技术的进一步发展应该为治疗癌症、心血管疾病、神经紊乱和传染病等棘手疾病带来令人兴奋的机会。